Found: 9
Select item for more details and to access through your institution.
Genetic studies of plasma analytes identify novel potential biomarkers for several complex traits.
- Published in:
- Scientific Reports, 2016, p. 18092, doi. 10.1038/srep18092
- By:
- Publication type:
- Article
Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease.
- Published in:
- Human Molecular Genetics, 2012, v. 21, n. 20, p. 4558, doi. 10.1093/hmg/dds296
- By:
- Publication type:
- Article
Genome-Wide Association Study of CSF Levels of 59 Alzheimer's Disease Candidate Proteins: Significant Associations with Proteins Involved in Amyloid Processing and Inflammation.
- Published in:
- PLoS Genetics, 2014, v. 10, n. 10, p. 1, doi. 10.1371/journal.pgen.1004758
- By:
- Publication type:
- Article
LOW PREVALENCE OF AMYLOID POSITIVITY IN HEALTHY ELDERLY PARTICIPANTS OF A METHODOLOGY STUDY EVALUATING REMOTE TABLET-BASED COGNITIVE LEARNING.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P1062, doi. 10.1016/j.jalz.2016.06.2219
- By:
- Publication type:
- Article
A potential endophenotype for Alzheimer’s disease: Cerebrospinal fluid clusterin.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P280, doi. 10.1016/j.jalz.2015.07.374
- By:
- Publication type:
- Article
Cerebrospinal fluid (CSF) vs. plasma-based biomarkers in Alzheimer's disease (AD), mild cognitive impaired (MCI) and age-matched healthy controls (HC) from the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort
- Published in:
- 2012
- By:
- Publication type:
- Abstract
Cerebrospinal fluid (CSF) biomarkers in Alzheimer's disease (AD), mild cognitively impaired (MCI) and age-matched healthy controls (HC) from the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort
- Published in:
- 2012
- By:
- Publication type:
- Abstract
Multiplexed Immunoassay Panel Identifies Novel CSF Biomarkers for Alzheimer's Disease Diagnosis and Prognosis.
- Published in:
- PLoS ONE, 2011, v. 6, n. 4, p. 1, doi. 10.1371/journal.pone.0018850
- By:
- Publication type:
- Article
Preclinical Evaluation of <sup>89</sup>Zr-Df-IAB22M2C PET as an Imaging Biomarker for the Development of the GUCY2C-CD3 Bispecific PF-07062119 as a T Cell Engaging Therapy.
- Published in:
- Molecular Imaging & Biology, 2021, v. 23, n. 6, p. 941, doi. 10.1007/s11307-021-01621-0
- By:
- Publication type:
- Article